https://www.zacks.com/stock/news/2238077/novo-nordisk-nvo-up-on-upbeat-data-from-new-obesity-pill-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238077
Mar 08, 2024 - Novo Nordisk (NVO) stock rises as it presents encouraging efficacy data on a new investigational oral obesity pill, amycretin, at its Capital Markets Day.
zc:-6632016347588930676
0
https://www.zacks.com/stock/news/2241296/pharma-stock-roundup-azn-s-new-acquisition-fda-updates-for-nvo-lly-and-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2241296
Mar 15, 2024 - AstraZeneca (AZN) is set to buy a private rare disease drugmaker. FDA delays decision on Lilly's (LLY) donanemab and approves Novo Nordisk's (NVO) Wegovy for reducing cardiovascular risks.
zc:-4303199437016293624
0
https://www.fool.com/investing/2024/03/17/3-unstoppable-stocks-you-can-buy-now-without-any/?source=iedfolrf0000001
Mar 17, 2024 - There's no need for delays in buying these great stocks.
0
fool:-3883354788635643214
0
https://www.zacks.com/stock/news/2245863/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2245863
Mar 26, 2024 - Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
zc:242395152607255597
0
https://www.zacks.com/stock/news/2246297/eli-lilly-lly-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2246297
Mar 26, 2024 - In the most recent trading session, Eli Lilly (LLY) closed at $774.90, indicating a +0.23% shift from the previous trading day.
zc:-7881593380053313524
0
https://www.fool.com/investing/2024/03/28/bull-market-buys-3-dividend-stocks-to-own-for-the/?source=iedfolrf0000001
Mar 28, 2024 - Invest in stability, dividends, and growth with these three accomplished real estate operators.
0
fool:-3107367675902370874
0
https://www.fool.com/investing/2024/03/28/stock-split-watch-are-these-2-top-growth-stocks/?source=iedfolrf0000001
Mar 28, 2024 - Shares of Eli Lilly and Regeneron are both well into the range where splits would make sense.
0
fool:326808553711399268
0
https://www.zacks.com/commentary/2248263/top-stock-reports-for-apple-nvidia-eli-lilly?cid=CS-ZC-FT-research_daily-2248263
Apr 01, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), NVIDIA Corporation (NVDA) and Eli Lilly and Company (LLY).
zc:9073020657858016534
0
https://www.zacks.com/stock/news/2252191/healthcare-etfs-for-the-weight-loss-drug-boom-beyond?cid=CS-ZC-FT-etf_spotlight-2252191
Apr 08, 2024 - We discuss attractive investment opportunities within the healthcare industry.
zc:5655903440061393347
0
https://www.fool.com/investing/2024/04/10/the-next-magnificent-seven/?source=iedfolrf0000001
Apr 10, 2024 - Here is a look at the stocks that might comprise the next "Magnificent Seven."
0
fool:-4580856102579854879
0